113 related articles for article (PubMed ID: 17508368)
1. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity.
Reina JJ; Sattin S; Invernizzi D; Mari S; Martínez-Prats L; Tabarani G; Fieschi F; Delgado R; Nieto PM; Rojo J; Bernardi A
ChemMedChem; 2007 Jul; 2(7):1030-6. PubMed ID: 17508368
[TBL] [Abstract][Full Text] [Related]
2. Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin.
Reina JJ; Díaz I; Nieto PM; Campillo NE; Páez JA; Tabarani G; Fieschi F; Rojo J
Org Biomol Chem; 2008 Aug; 6(15):2743-54. PubMed ID: 18633532
[TBL] [Abstract][Full Text] [Related]
3. Mannose glycoconjugates functionalized at positions 1 and 6. Binding analysis to DC-SIGN using biosensors.
Reina JJ; Maldonado OS; Tabarani G; Fieschi F; Rojo J
Bioconjug Chem; 2007; 18(3):963-9. PubMed ID: 17348701
[TBL] [Abstract][Full Text] [Related]
4. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel DC-SIGN ligands with an alpha-fucosylamide anchor.
Timpano G; Tabarani G; Anderluh M; Invernizzi D; Vasile F; Potenza D; Nieto PM; Rojo J; Fieschi F; Bernardi A
Chembiochem; 2008 Aug; 9(12):1921-30. PubMed ID: 18655085
[TBL] [Abstract][Full Text] [Related]
6. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
[TBL] [Abstract][Full Text] [Related]
7. 1D saturation transfer difference NMR experiments on living cells: the DC-SIGN/oligomannose interaction.
Mari S; Serrano-Gómez D; Cañada FJ; Corbí AL; Jiménez-Barbero J
Angew Chem Int Ed Engl; 2004 Dec; 44(2):296-8. PubMed ID: 15614901
[No Abstract] [Full Text] [Related]
8. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding.
Tabarani G; Reina JJ; Ebel C; Vivès C; Lortat-Jacob H; Rojo J; Fieschi F
FEBS Lett; 2006 May; 580(10):2402-8. PubMed ID: 16616922
[TBL] [Abstract][Full Text] [Related]
9. Saturation transfer difference (STD) NMR spectroscopy characterization of dual binding mode of a mannose disaccharide to DC-SIGN.
Angulo J; Díaz I; Reina JJ; Tabarani G; Fieschi F; Rojo J; Nieto PM
Chembiochem; 2008 Sep; 9(14):2225-7. PubMed ID: 18720494
[No Abstract] [Full Text] [Related]
10. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D
Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337
[TBL] [Abstract][Full Text] [Related]
11. Insights into molecular recognition of Lewis(X) mimics by DC-SIGN using NMR and molecular modelling.
Guzzi C; Angulo J; Doro F; Reina JJ; Thépaut M; Fieschi F; Bernardi A; Rojo J; Nieto PM
Org Biomol Chem; 2011 Oct; 9(22):7705-12. PubMed ID: 21984435
[TBL] [Abstract][Full Text] [Related]
12. Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering.
Guzzi C; Alfarano P; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Fieschi F; Bernardi A; Weiser J; Rojo J; Angulo J; Nieto PM
Org Biomol Chem; 2016 Jan; 14(1):335-44. PubMed ID: 26611567
[TBL] [Abstract][Full Text] [Related]
13. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site.
Chatwell L; Holla A; Kaufer BB; Skerra A
Mol Immunol; 2008 Apr; 45(7):1981-94. PubMed ID: 18061677
[TBL] [Abstract][Full Text] [Related]
14. Glycofullerenes inhibit viral infection.
Luczkowiak J; Muñoz A; Sánchez-Navarro M; Ribeiro-Viana R; Ginieis A; Illescas BM; Martín N; Delgado R; Rojo J
Biomacromolecules; 2013 Feb; 14(2):431-7. PubMed ID: 23281578
[TBL] [Abstract][Full Text] [Related]
15. Glycodendritic structures as DC-SIGN binders to inhibit viral infections.
Ramos-Soriano J; Rojo J
Chem Commun (Camb); 2021 May; 57(42):5111-5126. PubMed ID: 33977972
[TBL] [Abstract][Full Text] [Related]
16. Glycodendritic structures: promising new antiviral drugs.
Rojo J; Delgado R
J Antimicrob Chemother; 2004 Sep; 54(3):579-81. PubMed ID: 15308605
[TBL] [Abstract][Full Text] [Related]
17. DC-SIGN and immunoregulation.
Zhou T; Chen Y; Hao L; Zhang Y
Cell Mol Immunol; 2006 Aug; 3(4):279-83. PubMed ID: 16978536
[TBL] [Abstract][Full Text] [Related]
18. Influence of the reducing-end anomeric configuration of the Man
de la Cruz N; Ramos-Soriano J; Reina JJ; de Paz JL; Thépaut M; Fieschi F; Sousa-Herves A; Rojo J
Org Biomol Chem; 2020 Aug; 18(31):6086-6094. PubMed ID: 32729597
[TBL] [Abstract][Full Text] [Related]
19. Unraveling Sugar Binding Modes to DC-SIGN by Employing Fluorinated Carbohydrates.
Martínez JD; Valverde P; Delgado S; Romanò C; Linclau B; Reichardt NC; Oscarson S; Ardá A; Jiménez-Barbero J; Cañada FJ
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242623
[TBL] [Abstract][Full Text] [Related]
20. New lipophilic glycomimetic DC-SIGN ligands: Stereoselective synthesis and SPR-based binding inhibition assays.
Di Pietro S; Bordoni V; Iacopini D; Achilli S; Pineschi M; Thépaut M; Fieschi F; Crotti P; Di Bussolo V
Bioorg Chem; 2021 Feb; 107():104566. PubMed ID: 33387733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
